Companies that spend heavily on research and development (R&D) greatly improve their long-term odds. Dr Mike Tubbs explains what to look out for – and what to buy now.
Articles written by Dr Mike Tubbs
Companies with a consistent record of rising payouts look especially attractive at present. Dr Mike Tubbs introduces his favourite “dividend aristocrats”.
Few people have heard of Renishaw, but its products and prospects are excellent, says Mike Tubbs.
Salesforce, one of the world’s top software companies, has a bright future and is currently on sale.
Shares in German biotech MorphoSys firm could double as the royalties start to roll in, says Mike Tubbs.
You might not think of the UK as a market full of promising tech stocks. But our small- and medium-sized companies are punching above their weight, says Dr Mike Tubbs.
Biotech company Biogen’s promising treatment for the most common cause of dementia has just cleared a key hurdle.
Firms with strong brands, superior products or that exploit network effects are hard for competitors to keep up with. That means big profits for their investors. Mike Tubbs picks the best protected companies.
RWS is a “picks-and-shovels” play for the technology sector, and boasts an excellent record, says Mike Tubbs.
Science and engineering departments are innovation incubators, and regularly launch companies involved in a wide range of exciting new fields. Dr Mike Tubbs explains how to invest in spin-outs.